BRCA mutations in the management of breast cancer: the state of the art.
about
Tumor angiogenesis: pericytes and maturation are not to be ignoredEpigenetic changes of DNA repair genes in cancerBreast cancer survival among young women: a review of the role of modifiable lifestyle factorsFamilial risk for lung cancerThe impact of risk-reducing hysterectomy and bilateral salpingo-oophorectomy on survival in patients with a history of breast cancer--a population-based data linkage study.Genetic risk assessments in individuals at high risk for inherited breast cancer in the breast oncology care setting.BRCA1 missense polymorphisms are associated with poor prognosis of pancreatic cancer patients in a Chinese population.Identification of BRCA1 As a Potential Biomarker for Insulin-Like Growth Factor-1 Receptor Targeted Therapy in Breast Cancer.BRCA1 mRNA levels following a 4-6-week intervention with oral 3,3'-diindolylmethaneHow should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagEvaluating genomic tests from bench to bedside: a practical frameworkThe risk of primary and contralateral breast cancer after ovarian cancer in BRCA1/BRCA2 mutation carriers: Implications for counseling.Founder and Recurrent Mutations in BRCA1 and BRCA2 Genes in Latin American Countries: State of the Art and Literature Review.Novel neoadjuvant therapy paradigms for bladder cancer: results from the National Cancer Center Institute Forum.In their own words: treating very young BRCA1/2 mutation-positive women with care and caution.Prospective study of high-risk, BRCA1/2-mutation negative women: the 'negative study'Drug therapy for hereditary cancersIn Vitro Enhanced Sensitivity to Cisplatin in D67Y BRCA1 RING Domain Protein.Identification of a fragment-like small molecule ligand for the methyl-lysine binding protein, 53BP1.Evaluation of the Dutch BRCA1/2 clinical genetic center referral criteria in an unselected early breast cancer populationIdentification of a new class of natural product MDM2 inhibitor: In vitro and in vivo anti-breast cancer activities and target validation.Skp2 is a promising therapeutic target in breast cancer.Clinical Significance of Age at the Time of Diagnosis among Young Breast Cancer Patients.Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes.Inhibition of BRCT(BRCA1)-phosphoprotein interaction enhances the cytotoxic effect of olaparib in breast cancer cells: a proof of concept study for synthetic lethal therapeutic option.The Angelina Jolie Effect in Jewish Law: Prophylactic Mastectomy and Oophorectomy in BRCA CarriersA multi-case report of the pathways to and through genetic testing and cancer risk management for BRCA mutation-positive women aged 18-25.miRNA expression patterns in normal breast tissue and invasive breast cancers of BRCA1 and BRCA2 germ-line mutation carriers.Chemotherapy in Patients with Anthracycline- and Taxane-Pretreated Metastatic Breast Cancer: An Overview.p53 centrosomal localization diagnoses ataxia-telangiectasia homozygotes and heterozygotes.Poly(Adenosine diphosphate-ribose) polymerase inhibitors in cancer treatmentSystemic treatment for hereditary cancers: a 2012 update.Oncogenic miR-181a/b affect the DNA damage response in aggressive breast cancer.BRCA1 And BRCA2 analysis of Argentinean breast/ovarian cancer patients selected for age and family history highlights a role for novel mutations of putative south-American origin.Potential mechanisms for racial and ethnic differences in antimüllerian hormone and ovarian reserve.A Novel Pathogenic BRCA1 Splicing Variant Produces Partial Intron Retention in the Mature Messenger RNA.Tamoxifen for women at high risk of breast cancer.Seeking Genomic Knowledge: The Case for Clinical Restraint.Folate and breast cancer: what about high-risk women?Nucleic acid-based tissue biomarkers of urologic malignancies.
P2860
Q21296683-8E7273EF-8203-45AC-90C7-7010942F6C52Q22242858-DA768C60-2003-4653-ADCB-24D727462B1AQ26766205-C36524E3-6464-45BC-913A-62ACD8B2D23BQ29249088-628B22DB-980C-42AF-91A1-34F86B3010DBQ30677729-AB5D7FA4-A315-4D57-9894-C1266FD63C2FQ33564013-6EEEDCB8-17AF-4BE4-A3EF-646C16305CAFQ33829394-C5DE1A28-9129-4258-ADB7-EABE54EACC97Q33849329-A153BB21-54F4-44FB-85A0-4D282D9F2B14Q34283643-F2C10C64-5B85-4746-9F3B-F707116EB92AQ34354159-4E8E14A8-FDDF-431B-8599-2D457D5078D3Q34451291-E8274879-1B2C-44A8-A4BF-F9E1AD71B3E0Q34481713-3AE16EAB-4375-477E-93B2-4BD8702527F1Q34530426-A4245B27-EEC5-476C-9388-980BB1ED3802Q34670535-DD78C448-906B-464A-A5FB-847AA89895E3Q35105959-1329CADC-F532-4EAD-A86D-0AEF84ADE14EQ35130901-7DB4708F-84B9-4A64-A12D-3EA459AB4EBAQ35208929-8745E44D-A2B6-4B1D-9A2F-2F663C54C237Q35440379-6FEAA7DE-8A1A-47A0-904A-B93BA350AEB1Q35472154-F8A1C6F5-B068-4B0F-B185-BBFAEBC1ADE2Q35477949-FB86FE59-A353-4EF0-B7C1-9C5D6D0C8EFAQ35550054-07EF6A79-1F3F-4E1D-935E-72859516995BQ35687208-622E610D-A12C-47B7-9B98-33A2AEC42121Q35713872-F8A16DA4-270F-4A1C-86D6-4426EB22FD0EQ36105474-E0228042-885A-4B8B-AE7F-56AA257F20DEQ36110001-0609E37C-E203-4861-8878-87ACBD3E91FCQ36218446-D8DC1F14-D381-45E3-87FC-7E2765ABFA6CQ36487269-0F6A4C60-0510-4A3A-87AC-28BD773D6EBEQ36544789-C9B512E8-DE4B-472C-AF3C-2638DCD4A920Q36630732-20DE7F3C-68E5-49B7-9BBB-EE61F9918A84Q36638226-CD7CEAFF-1594-42EF-81ED-7EA4F6C018FCQ36693272-AE880727-1138-48F5-90D6-2C791DFD08B3Q36755366-D99852EC-B306-4CBB-9003-CCDFC15DF784Q37018223-0FDF691F-A926-4218-B512-374608DDB05DQ37052120-02E0C887-441D-43CF-A7BA-7985A637D8FFQ37379906-2FDA62DB-6169-45DA-AAA3-36AB2AD9F587Q37534958-8E0C3268-48B1-421E-A936-53A601DF9BC1Q37600675-48AEF228-BEFB-45D2-BA20-9DFEC49C5161Q37672307-1A25F112-1302-4943-8364-6B6E2A3E3C4BQ38024316-99A13F46-2F71-4BBB-AD74-70F47C98F6D7Q38216131-450727D7-10D5-4229-A162-1E052975ECF5
P2860
BRCA mutations in the management of breast cancer: the state of the art.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
BRCA mutations in the management of breast cancer: the state of the art.
@en
BRCA mutations in the management of breast cancer: the state of the art.
@nl
type
label
BRCA mutations in the management of breast cancer: the state of the art.
@en
BRCA mutations in the management of breast cancer: the state of the art.
@nl
prefLabel
BRCA mutations in the management of breast cancer: the state of the art.
@en
BRCA mutations in the management of breast cancer: the state of the art.
@nl
P2860
P1476
BRCA mutations in the management of breast cancer: the state of the art.
@en
P2093
Steven A Narod
P2860
P304
P356
10.1038/NRCLINONC.2010.166
P407
P577
2010-10-19T00:00:00Z